Sort   by:  
 Page size 
UnknownVandetanib in patients with locally advanced or metastatic medullary thyroid cancer: a randomized, double-blind phase III trial.
Not available
S-EPMC3675689 | biostudies-literature
UnknownCabozantinib in progressive medullary thyroid cancer.
Not available
S-EPMC4164813 | biostudies-literature
TranscriptomicsGene signature of the post-Chernobyl papillary thyroid cancer
Thyroid gland is among the most sensitive organs to ionizing radiation. Whether low-dose radiation-induced papillary thyroid cancer (PTC) differs from sporadic PTC is yet unknown. We used microarrays to identify gene signature of radiation-induced papillary thyroid carcinomas To identify molecular d...
ORGANISM(S): Homo sapiens 
2015-12-31 | E-GEOD-35570 | biostudies-arrayexpress
TranscriptomicsGene expression signature associated with BRAFV600E mutation based on transgenic mouse model (mouse)
BRAFV600E mutation is the most frequent molecular event in papillary thyroid carcinoma. The relation of this genetic alteration with the factors od poor prognosis has been reported as well as its influence on PTC gene signature. However human material disables distinction of cancer causes from its e...
ORGANISM(S): Mus musculus 
2015-12-31 | E-GEOD-58546 | biostudies-arrayexpress
TranscriptomicsGene expression signature associated with BRAFV600E mutation in human papillary thyroid carcinoma based on transgenic mouse model (human)
BRAFV600E mutation is the most frequent molecular event in papillary thyroid carcinoma. The relation of this genetic alteration with the factors od poor prognosis has been reported as well as its influence on PTC gene signature. However human material disables distinction of cancer causes from its e...
ORGANISM(S): Homo sapiens 
2015-12-31 | E-GEOD-58545 | biostudies-arrayexpress
Sort   by:  
 Page size